ARROWHEAD PHARMACEUTICALS, INC. Operating Leases, Rent Expense
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) reported Operating Leases, Rent Expense of $4.92 million for the 131-month period ending 2014-03-31, per its 10-Q filed 2014-05-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseAndRentalExpense · last filed 2014-05-06
- 2014-03-31: .
- 2013-12-31: .
- 2013-09-30: .
- 2013-06-30: .
| Period end | Operating Leases, Rent Expense 1 month | Operating Leases, Rent Expense 9 month | Operating Leases, Rent Expense 113 month | Operating Leases, Rent Expense 116 month | Operating Leases, Rent Expense 119 month | Operating Leases, Rent Expense 122 month | Operating Leases, Rent Expense 125 month | Operating Leases, Rent Expense 128 month | Operating Leases, Rent Expense 131 month |
|---|---|---|---|---|---|---|---|---|---|
| 2014-03-31 | $4.92M 10-Q · filed 2014-05-06 | ||||||||
| 2013-12-31 | $4.79M 10-Q · filed 2014-02-04 | ||||||||
| 2013-09-30 | $4.66M 10-K · filed 2013-12-18 | ||||||||
| 2013-06-30 | $4.53M 10-Q · filed 2013-08-07 | ||||||||
| 2013-03-31 | $4.41M 10-Q · filed 2013-05-09 | ||||||||
| 2012-12-31 | $4.27M 10-Q · filed 2013-02-13 | ||||||||
| 2012-09-30 | $4.13M 10-K · filed 2012-12-28 | ||||||||
| 2012-08-31 | $13.00K 10-K · filed 2013-12-18 | ||||||||
| 2012-06-30 | $3.99M 10-Q · filed 2012-08-13 | ||||||||
| 2011-04-30 | $8.00K 10-Q · filed 2012-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |